AstraZeneca has recently been investing heavily in the cell therapy space, including two acquisitions for TeneoTwo and ...

The UK drugmaker AstraZeneca has agreed to acquire Belgian cell therapy developer EsoBiotec for up to $1bn to enhance its cancer treatment capabilities. Read more.

The incidence and prevalence of eosinophilic esophagitis in the United States are higher than previously reported, indicating increased disease burden, according to a poster presented here. EoE can ...

Recent health news highlights include Bayer's optimism over Georgia's new law against glyphosate litigation, AstraZeneca's $1 ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target ...

The UK's FTSE 100 index increased slightly, aided by energy and metal mining sectors, as investors anticipated central bank ...

The mid-cap FTSE 250 index was down 0.2%, dragged by a 21.5% slump in shares of QinetiQ. The defence and security company ...

The Anti-Corruption Commission (ACC) has launched an investigation into allegations of irregularities against Beximco ...

Partex's platform will provide comprehensive analyses, including target identification, indication expansion, and molecular profiling, ultimately accelerating the process of bringing innovative ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

Remission persisted through 104 weeks for most patients with eosinophilic granulomatosis with polyangiitis who used benralizumab, according to a poster presented here. Lower blood eosinophil counts ...